Literature DB >> 20484145

Gene expression profiles of human glioblastomas are associated with both tumor cytogenetics and histopathology.

Ana Luísa Vital1, Maria Dolores Tabernero, Abel Castrillo, Olinda Rebelo, Hermínio Tão, Fernando Gomes, Ana Belen Nieto, Catarina Resende Oliveira, Maria Celeste Lopes, Alberto Orfao.   

Abstract

Despite the increasing knowledge about the genetic alterations and molecular pathways involved in gliomas, few studies have investigated the association between the gene expression profiles (GEP) and both cytogenetics and histopathology of gliomas. Here, we analyzed the GEP (U133Plus2.0 chip) of 40 gliomas (35 astrocytic tumors, 3 oligodendrogliomas, and 2 mixed tumors) and their association with tumor cytogenetics and histopathology. Unsupervised and supervised analyses showed significantly different GEP in low- vs high-grade gliomas, the most discriminating genes including genes involved in the regulation of cell proliferation, apoptosis, DNA repair, and signal transduction. In turn, among glioblastoma multiforme (GBM), 3 subgroups of tumors were identified according to their GEP, which were closely associated with the cytogenetic profile of their ancestral tumor cell clones: (i) EGFR amplification, (ii) isolated trisomy 7, and (iii) more complex karyotypes. In summary, our results show a clear association between the GEP of gliomas and tumor histopathology; additionally, among grade IV astrocytoma, GEP are significantly associated with the cytogenetic profile of the ancestral tumor cell clone. Further studies in larger series of patients are necessary to confirm our observations.

Entities:  

Mesh:

Year:  2010        PMID: 20484145      PMCID: PMC2940695          DOI: 10.1093/neuonc/noq050

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  47 in total

1.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

Authors:  Rafael A Irizarry; Bridget Hobbs; Francois Collin; Yasmin D Beazer-Barclay; Kristen J Antonellis; Uwe Scherf; Terence P Speed
Journal:  Biostatistics       Date:  2003-04       Impact factor: 5.899

2.  Gene expression profiling of gliomas strongly predicts survival.

Authors:  William A Freije; F Edmundo Castro-Vargas; Zixing Fang; Steve Horvath; Timothy Cloughesy; Linda M Liau; Paul S Mischel; Stanley F Nelson
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

3.  Control of cell proliferation and apoptosis by mob as tumor suppressor, mats.

Authors:  Zhi-Chun Lai; Xiaomu Wei; Takeshi Shimizu; Edward Ramos; Margaret Rohrbaugh; Nikolas Nikolaidis; Li-Lun Ho; Ying Li
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

4.  Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?

Authors:  José María Sayagués; María Dolores Tabernero; Angel Maíllo; Ana Espinosa; Ana Rasillo; Pedro Díaz; Juana Ciudad; Antonio López; Marta Merino; Jesús María Gonçalves; Angel Santos-Briz; Francisco Morales; Alberto Orfao
Journal:  J Mol Diagn       Date:  2004-11       Impact factor: 5.568

5.  Molecular stratification of diagnostically challenging high-grade gliomas composed of small cells: the utility of fluorescence in situ hybridization.

Authors:  Andrey Korshunov; Regina Sycheva; Andrey Golanov
Journal:  Clin Cancer Res       Date:  2004-12-01       Impact factor: 12.531

6.  Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas.

Authors:  C Bouvier-Labit; O Chinot; C Ochi; D Gambarelli; H Dufour; D Figarella-Branger
Journal:  Neuropathol Appl Neurobiol       Date:  1998-10       Impact factor: 8.090

7.  Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.

Authors:  Yoshikazu Okamoto; Pier-Luigi Di Patre; Christoph Burkhard; Sonja Horstmann; Benjamin Jourde; Michael Fahey; Danielle Schüler; Nicole M Probst-Hensch; M Gazi Yasargil; Yasuhiro Yonekawa; Urs M Lütolf; Paul Kleihues; Hiroko Ohgaki
Journal:  Acta Neuropathol       Date:  2004-04-28       Impact factor: 17.088

8.  Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction.

Authors:  Jörg van den Boom; Marietta Wolter; Rork Kuick; David E Misek; Andrew S Youkilis; Daniel S Wechsler; Clemens Sommer; Guido Reifenberger; Samir M Hanash
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

Review 9.  Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy.

Authors:  Paul S Mischel; Stanley F Nelson; Timothy F Cloughesy
Journal:  Cancer Biol Ther       Date:  2003 May-Jun       Impact factor: 4.742

10.  HMGB1 mediates endogenous TLR2 activation and brain tumor regression.

Authors:  James F Curtin; Naiyou Liu; Marianela Candolfi; Weidong Xiong; Hikmat Assi; Kader Yagiz; Matthew R Edwards; Kathrin S Michelsen; Kurt M Kroeger; Chunyan Liu; A K M Ghulam Muhammad; Mary C Clark; Moshe Arditi; Begonya Comin-Anduix; Antoni Ribas; Pedro R Lowenstein; Maria G Castro
Journal:  PLoS Med       Date:  2009-01-13       Impact factor: 11.069

View more
  27 in total

1.  Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma.

Authors:  Drew Pratt; Stefania Pittaluga; Maryknoll Palisoc; Patricia Fetsch; Liqiang Xi; Mark Raffeld; Mark R Gilbert; Martha Quezado
Journal:  J Neuropathol Exp Neurol       Date:  2017-08-01       Impact factor: 3.685

Review 2.  Embryonal Fyn-associated substrate (EFS) and CASS4: The lesser-known CAS protein family members.

Authors:  Alexander Deneka; Vladislav Korobeynikov; Erica A Golemis
Journal:  Gene       Date:  2015-06-26       Impact factor: 3.688

3.  miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma.

Authors:  Lijoy K Mathew; Nicolas Skuli; Vera Mucaj; Samuel S Lee; Pascal O Zinn; Pratheesh Sathyan; Hongxia Z Imtiyaz; Zhongfa Zhang; Ramana V Davuluri; Shilpa Rao; Sriram Venneti; Priti Lal; Justin D Lathia; Jeremy N Rich; Brian Keith; Andy J Minn; M Celeste Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-24       Impact factor: 11.205

4.  Programmed Death Ligand 1 Is a Negative Prognostic Marker in Recurrent Isocitrate Dehydrogenase-Wildtype Glioblastoma.

Authors:  Drew Pratt; Gifty Dominah; Graham Lobel; Arnold Obungu; John Lynes; Victoria Sanchez; Nicholas Adamstein; Xiang Wang; Nancy A Edwards; Tianxia Wu; Dragan Maric; Amber J Giles; Mark R Gilbert; Martha Quezado; Edjah K Nduom
Journal:  Neurosurgery       Date:  2019-08-01       Impact factor: 4.654

5.  DNA methylome and transcriptome analysis established a model of four differentially methylated positions (DMPs) as a diagnostic marker in esophageal adenocarcinoma early detection.

Authors:  Weilin Peng; Guangxu Tu; Zhenyu Zhao; Boxue He; Qidong Cai; Pengfei Zhang; Xiong Peng; Shuai Shi; Xiang Wang
Journal:  PeerJ       Date:  2021-05-07       Impact factor: 2.984

6.  Amplified and homozygously deleted genes in glioblastoma: impact on gene expression levels.

Authors:  Inês Crespo; Hermínio Tão; Ana Belen Nieto; Olinda Rebelo; Patrícia Domingues; Ana Luísa Vital; Maria del Carmen Patino; Marcos Barbosa; Maria Celeste Lopes; Catarina Resende Oliveira; Alberto Orfao; María Dolores Tabernero
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

7.  Deregulation of ion channel and transporter encoding genes in pediatric gliomas.

Authors:  Marika Masselli; Pasquale Laise; Giulia Tonini; Duccio Fanelli; Serena Pillozzi; Valentina Cetica; Martina Da Ros; Iacopo Sardi; Anna Maria Buccoliero; Maurizio Aricò; Lorenzo Genitori; Andrea Becchetti; Annarosa Arcangeli
Journal:  Front Oncol       Date:  2012-05-30       Impact factor: 6.244

8.  Familial glioblastoma: A case report of glioblastoma in two brothers and review of literature.

Authors:  Ifeoma Ugonabo; Nader Bassily; Alexandra Beier; Jacky T Yeung; Lynette Hitchcock; Frances De Mattia; Aftab Karim
Journal:  Surg Neurol Int       Date:  2011-10-29

9.  Comparative analysis of methods for identifying recurrent copy number alterations in cancer.

Authors:  Xiguo Yuan; Junying Zhang; Shengli Zhang; Guoqiang Yu; Yue Wang
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  Ion channel gene expression predicts survival in glioma patients.

Authors:  Rong Wang; Christopher I Gurguis; Wanjun Gu; Eun A Ko; Inja Lim; Hyoweon Bang; Tong Zhou; Jae-Hong Ko
Journal:  Sci Rep       Date:  2015-08-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.